Placental Growth Factor and Cardiac Inflammation

Trends in Cardiovascular Medicine

Volumn 22, Issue 8, 2012, Pages 209-212

  Carnevale, Daniela ^a,b   Lembo, Giuseppe ^a,b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PLACENTAL GROWTH FACTOR; PROTEIN ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR INFLAMMATION; CELL SURVIVAL; CHEMOTAXIS; DRUG TARGETING; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HUMAN; IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84869045313     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.022     Document Type: Review

References (28)

1. Accornero F., van Berlo J.H., Benard M.J., et al. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 2011, 109:272-280.
2. Autiero M., Luttun A., Tjwa M., Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: Novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003, 1:1356-1370.
3. Black R.A. TIMP3 checks inflammation. Nat Genet 2004, 36:934-935.
4. Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001, 7:575-583.
5. Carnevale D., Cifelli G., Mascio G., et al. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α-converting enzyme axis: Crucial role for adaptive cardiac remodeling during cardiac pressure overload. Circulation 2011, 124:1337-1350.
6. Clauss M., Weich H., Breier G., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996, 271:17629-17634.
7. De Falco S., Gigante B., Persico M.G. Structure and function of placental growth factor. Trends Cardiovasc Med 2002, 12:241-246.
8. DiSalvo J., Bayne M.L., Conn G., et al. Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer. J Biol Chem 1995, 270:7717-7723.
9. Endo J., Sano M., Fujita J., et al. Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation 2007, 116:1176-1184.
10. Fischer P., Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: The gp130-STAT axis. Basic Res Cardiol 2007, 102:393-411.
11. Iyer S., Leonidas D.D., Swaminathan G.J., et al. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem 2001, 276:12153-12161.
12. Izumiya Y., Shiojima I., Sato K., et al. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006, 47:887-893.
13. Knuefermann P., Vallejo J., Mann D.L. The role of innate immune responses in the heart in health and disease. Trends Cardiovasc Med 2004, 14:1-7.
14. Koch S., Tugues S., Li X., et al. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011, 437:169-183.
15. Luttun A., Tjwa M., Moons L., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002, 8:831-840.
16. Maglione D., Guerriero V., Viglietto G., et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991, 88:9267-9271.
17. Maglione D., Guerriero V., Viglietto G., et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 1993, 8:925-931.
18. Park J.E., Chen H.H., Winer J., et al. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994, 269:25646-25654.
19. Patel N., Gonsalves C.S., Malik P., Kalra V.K. Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha. Blood 2008, 112:856-865.
20. Perelman N., Selvaraj S.K., Batra S., et al. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood 2003, 102:1506-1514.
21. Pipp F., Heil M., Issbrücker K., et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: Evidence for a monocyte-mediated mechanism. Circ Res 2003, 92:378-385.
22. Roncal C., Buysschaert I., Chorianopoulos E., et al. Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 2008, 216:236-244.
23. Selvaraj S.K., Giri R.K., Perelman N., et al. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003, 102:1515-1524.
24. Shiojima I., Sato K., Izumiya Y., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005, 115:2108-2118.
25. Walsh K., Shiojima I. Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 2007, 117:3176-3179.
26. Wang X., Oka T., Chow F.L., et al. Tumor necrosis factor-α-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis. Hypertension 2009, 54:575-582.
27. Wilson E.M., Diwan A., Spinale F.G., Mann D.L. Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mol Cell Cardiol 2004, 37:801-811.
28. Zentilin L., Puligadda U., Lionetti V., et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J 2010, 24:1467-1478.